Literature DB >> 714117

Fallacy of the five-year survival in lung cancer.

B J McNeil, R Weichselbaum, S G Pauker.   

Abstract

Patients with lung cancer can be treated by either surgical extirpation or radiation. The former may offer increased five-year survival and prolonged life expectancies as compared to the latter, but subjects patients to the immediate risk of thoracotomy. We interviewed patients with "operable" lung cancer and found that they were quite averse to taking risks involving the possibility of immediate death. When these data about patients' attitudes were combined with data about survival after both radiation therapy and operation, it appeared that radiotherapy would be the preferred therapeutic plan for several of these patients. These results emphasize the importance of choosing therapies not only on the basis of objective measures of survival but also on the basis of patient attitudes.

Entities:  

Mesh:

Year:  1978        PMID: 714117     DOI: 10.1056/NEJM197812212992506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  51 in total

1.  [Statistically significant--also relevant for the patient?].

Authors:  S Lange
Journal:  Med Klin (Munich)       Date:  1999-04-15

Review 2.  Benefit valuation in economic evaluation of cancer therapies. A systematic review of the published literature.

Authors:  J Brown; M Sculpher
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

3.  Differences in belief about likely outcomes account for differences in doctors' treatment preferences: but what accounts for the differences in belief?

Authors:  T Rakow
Journal:  Qual Health Care       Date:  2001-09

4.  First principles of cost-effectiveness analysis in health.

Authors:  D S Shepard; M S Thompson
Journal:  Public Health Rep       Date:  1979 Nov-Dec       Impact factor: 2.792

5.  Interpretation of graphic data by patients in a general medicine clinic.

Authors:  D J Mazur; D H Hickam
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

Review 6.  Managing patients with inexplicable health problems.

Authors:  Baruch Fischhoff; Simon Wessely
Journal:  BMJ       Date:  2003-03-15

Review 7.  The promise of empirical research in the study of informed consent theory and practice.

Authors:  Laura A Siminoff; Marie Caputo; Christopher Burant
Journal:  HEC Forum       Date:  2004-03

8.  Studying patients' preferences in health care decision making. Health Services Research Group.

Authors: 
Journal:  CMAJ       Date:  1992-09-15       Impact factor: 8.262

9.  Time preference for health gains versus health losses.

Authors:  L D MacKeigan; L N Larson; J R Draugalis; J L Bootman; L R Burns
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

10.  Preference based outcome measures for economic evaluation of drug interventions: quality adjusted life years (QALYs) versus healthy years equivalents (HYEs).

Authors:  A Mehrez; A Gafni
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.